FC
CRL icon

Financial Consulate’s Charles River Laboratories CRL Stock Holding History

Financial Consulate’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908 Buy
+4
New +$712 ﹤0.01% 1181

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Financial Consulate's CRL Position: Q2 2026 in Review

Financial Consulate opened a new position in Charles River Laboratories (CRL) in Q2 2026: 4 shares worth $908. The stake represents ﹤0.01% of the portfolio and ranks #1181 among its holdings.

563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Financial Consulate held 4 shares of Charles River Laboratories worth $908 as of Q2 2026.
  • Charles River Laboratories was a new Financial Consulate position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #1181 holding.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.